▸ 22 Oct 2026, 08:18 RLS-2202 Phase 1a Trial Advances to Cohort 2 Company Update
▸ 13 Oct 2026, 08:12 Investor Presentation Presentations
▸ 6 Oct 2026, 10:26 Investor Webinar Presentations
▸ 5 Oct 2026, 19:34 Date of AGM and Closing Date for Director Nominations Meetings & Governance
▸ 30 Sep 2026, 16:53 Notification of cessation of securities - PAB Securities Administration
▸ 29 Sep 2026, 08:13 Patrys Completes Cohort 1 Dosing and Follow-Up Company Update
▸ 28 Sep 2026, 17:32 Appendix 4E Variance Report Financial Results
▸ 28 Sep 2026, 17:32 Annual Report - 30 June 2025 Financial Results
▸ 28 Sep 2026, 17:26 Appendix 4G and Corporate Governance Statement Company Administration
▸ 23 Sep 2026, 08:57 First Participants Dosed in RLS-2202 Phase 1A Clinical Trial Company Update
▸ 17 Sep 2026, 08:32 PAB Establishes Clinical Advisory Committee Company Update
▸ 31 Aug 2026, 19:03 Appendix 4E - Preliminary Final Report Financial Results
▸ 28 Aug 2026, 08:12 Ethics Approval Secured for Phase 1A Clinical Trial Company Update
▸ 27 Jul 2026, 08:28 Investor Presentation - TechKnow Invest Roadshow Presentations
▸ 22 Jul 2026, 09:35 Appendix 4C - Quarterly - 30 June 2026 Quarterly Reports
▸ 15 Jul 2026, 18:13 Cleansing Notice Securities Administration
▸ 15 Jul 2026, 18:12 Notification regarding unquoted securities - PAB Securities Administration
▸ 15 Jul 2026, 18:08 Application for quotation of securities - PAB Securities Administration
▸ 13 Jul 2026, 08:22 Patrys Secures 50% Revenue Share in IP Commercialisation Company Update
▸ 7 Jul 2026, 18:14 Becoming a substantial holder Substantial Holders
▸ 3 Jul 2026, 18:14 Change of Director's Interest Notices x4 Director Interests
▸ 3 Jul 2026, 18:11 Notification regarding unquoted securities - PAB Securities Administration
▸ 3 Jul 2026, 18:09 Cleansing Notice Securities Administration
▸ 3 Jul 2026, 18:06 Application for quotation of securities - PAB Securities Administration
▸ 9 Jun 2026, 08:28 Proposed issue of securities - PAB Securities Administration
▸ 9 Jun 2026, 08:26 Results of Meeting Meetings & Governance
▸ 20 May 2026, 09:31 Patrys advances RLS-2202 toward Phase 1 Clinical Trial Company Update
▸ 15 May 2026, 18:20 Appendix 4C - Quarterly - 31 March 2026 - Updated Quarterly Reports
▸ 6 May 2026, 08:17 Letter to Shareholders - General Meeting Meetings & Governance
▸ 6 May 2026, 08:17 Notice of General Meeting/Proxy Form Meetings & Governance
▸ 30 Apr 2026, 09:13 Appendix 4C - Quarterly - 31 March 2026 Quarterly Reports
▸ 29 Apr 2026, 08:48 Cleansing Notice Securities Administration
▸ 29 Apr 2026, 08:44 Application for quotation of securities - PAB Securities Administration
▸ 20 Apr 2026, 09:31 Proposed issue of securities - PAB Securities Administration
▸ 20 Apr 2026, 09:31 $3.2 million Placement to Advance Clinical Trials Capital Raising
▸ 16 Apr 2026, 08:53 Trading Halt Trading Halt / Suspension
▸ 31 Mar 2026, 08:21 Investor Presentation - Broker Meets Biotech Presentations
▸ 18 Mar 2026, 19:36 Notification of cessation of securities - PAB Securities Administration
▸ 13 Mar 2026, 18:34 Change of Share Registry Details Securities Administration
▸ 11 Mar 2026, 08:23 RLS-2201 Manufacturing and Regulatory Pathway Initiated Company Update
▸ 26 Feb 2026, 18:12 Appendix 4D - Half Year Accounts - 31 December 2025 Financial Results
▸ 16 Feb 2026, 08:13 CEO Commences Role Company Administration
▸ 12 Feb 2026, 08:13 Appointment of Chief Executive Officer Company Administration
▸ 10 Feb 2026, 19:17 Change of Director's Interest Notice - BL Director Interests
▸ 10 Feb 2026, 19:11 Cleansing Notice Securities Administration
▸ 10 Feb 2026, 19:10 Notification regarding unquoted securities - PAB Securities Administration
▸ 10 Feb 2026, 19:05 Application for quotation of securities - PAB Securities Administration
▸ 2 Feb 2026, 18:31 Initial Director's Interest Notice x2 Director Interests
▸ 30 Jan 2026, 08:17 Appendix 4C - Quarterly - 31 December 2025 Quarterly Reports
▸ 29 Jan 2026, 08:18 Notification regarding unquoted securities - PAB Securities Administration
▸ 29 Jan 2026, 08:18 Application for quotation of securities - PAB Securities Administration
▸ 29 Jan 2026, 08:17 Cleansing Prospectus Securities Administration
▸ 28 Jan 2026, 09:37 Investor Presentation Mergers & Acquisitions
▸ 28 Jan 2026, 09:36 Completion of Acquisition and Board Appointments Mergers & Acquisitions
▸ 19 Jan 2026, 19:38 Results of Meeting Meetings & Governance
▸ 12 Dec 2025, 19:55 Letter to Shareholders - General Meeting Meetings & Governance
▸ 12 Dec 2025, 19:51 Notice of General Meeting/Proxy Form Meetings & Governance
▸ 26 Nov 2025, 09:14 Pipeline Expanded with Proprietary Injectable Antipsychotic Mergers & Acquisitions
▸ 24 Nov 2025, 09:04 Trading Halt Trading Halt / Suspension
▸ 10 Nov 2025, 13:29 Final Director's Interest Notice Director Interests
▸ 10 Nov 2025, 13:25 Initial Director's Interest Notice Director Interests
▸ 10 Nov 2025, 09:03 Changes to Board, Company Secretary and Office Address Company Administration
▸ 30 Oct 2025, 09:53 Appendix 4C - Quarterly - 30 September 2025 Quarterly Reports
▸ 30 Oct 2025, 09:47 Patrys Receives R&D Tax Incentive Refund Company Administration
▸ 28 Oct 2025, 16:04 Change of Director's Interest Notices x3 Director Interests
▸ 22 Oct 2025, 17:48 Post-Consolidation Appendices 3Y Director Interests
▸ 22 Oct 2025, 14:49 Updated Capital Structure Company Administration
▸ 22 Oct 2025, 08:23 Notification regarding unquoted securities - PAB Securities Administration
▸ 22 Oct 2025, 08:23 Notification regarding unquoted securities - PAB Securities Administration
▸ 22 Oct 2025, 08:23 Notification regarding unquoted securities - PAB Securities Administration
▸ 22 Oct 2025, 08:23 Notification regarding unquoted securities - PAB Securities Administration
▸ 22 Oct 2025, 08:23 Application for quotation of securities - PAB Securities Administration
▸ 22 Oct 2025, 08:23 Application for quotation of securities - PAB Securities Administration
▸ 22 Oct 2025, 08:23 Application for quotation of securities - PAB Securities Administration
▸ 22 Oct 2025, 08:23 Application for quotation of securities - PAB Securities Administration
▸ 22 Oct 2025, 08:23 Application for quotation of securities - PAB Securities Administration
▸ 22 Oct 2025, 08:22 Application for quotation of securities - PAB Securities Administration
▸ 16 Oct 2025, 12:38 Completion of Share Consolidation Securities Administration
▸ 9 Oct 2025, 19:00 Results of Annual General Meeting Meetings & Governance
▸ 7 Oct 2025, 17:12 Change of Director's Interest Notice Director Interests
▸ 7 Oct 2025, 17:03 Notification of cessation of securities - PAB Securities Administration
▸ 8 Sep 2025, 09:15 Consolidation/Split - PAB Securities Administration
▸ 8 Sep 2025, 09:11 Notice of Annual General Meeting/Proxy Form Meetings & Governance
▸ 5 Sep 2025, 19:03 Appendix 4G and Corporate Governance Statement Company Administration
▸ 5 Sep 2025, 18:58 Annual Report - 30 June 2025 Financial Results
▸ 5 Sep 2025, 16:22 Becoming a substantial holder Substantial Holders
▸ 5 Sep 2025, 16:17 Change of Director's Interest Notices x2 Director Interests
▸ 4 Sep 2025, 11:51 Application for quotation of securities - PAB Securities Administration
▸ 29 Aug 2025, 18:23 Change of Director's Interest Notice Director Interests
▸ 29 Aug 2025, 14:46 Appendix 4E - Preliminary Final Report Financial Results
▸ 28 Aug 2025, 09:31 Application for quotation of securities - PAB Securities Administration
▸ 27 Aug 2025, 09:54 Results of Entitlement Offer Capital Raising
▸ 6 Aug 2025, 09:50 Entitlement Offer - Letter to Ineligible Shareholders Capital Raising
▸ 6 Aug 2025, 09:45 Entitlement Offer Open/Despatch Letter Eligible Shareholders Capital Raising